CorrectionCorrection
Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry
The Journal of Rheumatology January 2013, 40 (1) 106; DOI: https://doi.org/10.3899/jrheum.120583.CI
In this issue
The Journal of Rheumatology
Vol. 40, Issue 1
1 Jan 2013
Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry
The Journal of Rheumatology Jan 2013, 40 (1) 106; DOI: 10.3899/jrheum.120583.CI